Atlas Trials

Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

Clinical trial NCT05664555 · COMPLETED

Trial details

NCT number
NCT05664555
Sponsor
Seoul National University Bundang Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Retinal Disease
Start date
2023-02-01
Primary completion
2024-03-31
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.